Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("WALEWSKI, Jan")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 16 of 16

  • Page / 1
Export

Selection :

  • and

Randomized Comparison of Cladribine Alone or in Combination With Cyclophosphamide, and Cyclophosphamide, Vincristine and Prednisone in Previously Untreated Low-Grade B-Cell Non-Hodgkin Lymphoma Patients : Final Report of the Polish Lymphoma Research GroupKALINKA-WARZOCHA, Ewa; WAJS, Jaroslaw; LECH-MARANDA, Ewa et al.Cancer. 2008, Vol 113, Num 2, pp 367-375, issn 0008-543X, 9 p.Article

First clinical use of ofatumumab, a novel fully human anti-CD20 monoclonal antibody in relapsed or refractory follicular lymphoma : results of a phase 1/2 trialHAGENBEEK, Anton; GADEBERG, Ole; KNEBA, Michael et al.Blood. 2008, Vol 111, Num 12, pp 5486-5495, issn 0006-4971, 10 p.Article

Comparison of ABVD and alternating or hybrid multidrug regimens for the treatment of advanced Hodgkin's lymphoma : Results of the United Kingdom lymphoma group LY09 trial (ISRCTN97144519)JOHNSON, Peter W. M; RADFORD, John A; RYDER, David et al.Journal of clinical oncology. 2005, Vol 23, Num 36, pp 9208-9218, issn 0732-183X, 11 p.Article

Outcome of adult patients with T-lymphoblastic lymphoma treated according to protocols for acute lymphoblastic leukemiaHOELZER, Dieter; GÖKBUGET, Nicola; DIGEL, Werner et al.Blood. 2002, Vol 99, Num 12, pp 4379-4385, issn 0006-4971Article

Recovery of dendritic cell counts and function in peripheral blood of cancer patients after chemotherapyMARKOWICZ, Sergiusz; WALEWSKI, Jan; ZAJDA, Katarzyna et al.Cytokines, cellular & molecular therapy. 2002, Vol 7, Num 1, pp 15-24, issn 1368-4736Article

Confirmation of the Mantle-Cell Lymphoma International Prognostic Index in Randomized Trials of the European Mantle-Cell Lymphoma NetworkHOSTER, Eva; KLAPPER, Wolfram; STILGENBAUER, Stephan et al.Journal of clinical oncology. 2014, Vol 32, Num 13, pp 1338-1346, issn 0732-183X, 9 p.Article

Molecular remission is an independent predictor of clinical outcome in patients with mantle cell lymphoma after combined immunochemotherapy: a European MCL intergroup studyPOTT, Christiane; HOSTER, Eva; VAN DONGEN, Jacques J. M et al.Blood. 2010, Vol 115, Num 16, pp 3215-3223, issn 0006-4971, 9 p.Article

Procollagen I amino-terminal propeptide as a potential marker for multiple myelomaKOWALSKA, Maria; DRUZD-SITEK, Agnieszka; FUKSIEWICZ, Malgorzata et al.Clinical biochemistry. 2010, Vol 43, Num 6, pp 604-608, issn 0009-9120, 5 p.Article

A prospective clinicopathologic study of dose-modified CODOX-M/TVAC in patients with sporadic Burkitt lymphoma defined using cytogenetic and immunophenotypic criteria (MRC/NCRI LY10 trial)MEAD, Graham M; BARRANS, Sharon L; WENDI QIAN et al.Blood. 2008, Vol 112, Num 6, pp 2248-2260, issn 0006-4971, 13 p.Article

Bendamustine as Monotherapy and in Combination Regimens for the Treatment of Chronic Lymphocytic Leukemia and Non-Hodgkin Lymphoma: A Retrospective AnalysisHUS, Iwona; JAWNIAK, Dariusz; WIKTOR JEDRZEJCZAK, W et al.Chemotherapy (Basel). 2013, Vol 59, Num 4, pp 280-289, issn 0009-3157, 10 p.Article

Effect of Cytochrome P450 3A4 Inducers on the Pharmacokinetic, Pharmacodynamic and Safety Profiles of Bortezomib in Patients with Multiple Myeloma or Non-Hodgkin's LymphomaHELLMANN, Andrzej; RULE, Simon; WALEWSKI, Jan et al.Clinical pharmacokinetics. 2011, Vol 50, Num 12, pp 781-791, issn 0312-5963, 11 p.Article

Pharmacokinetics and pharmacokinetic/pharmacodynamic associations of ofatumumab, a human monoclonal CD20 antibody, in patients with relapsed or refractory chronic lymphocytic leukaemia: a phase 1-2 studyCOIFFIER, Bertrand; LOSIC, Nedjad; HOLOWIECKI, Jerzy et al.British journal of haematology. 2010, Vol 150, Num 1, pp 58-71, issn 0007-1048, 14 p.Article

Safety and efficacy of ofatumumab, a fully human monoclonal anti-CD20 antibody, in patients with relapsed or refractory B-cell chronic lymphocytic leukemia : a phase 1-2 studyCOIFFIER, Bertrand; LEPRETRE, Stéphane; WALEWSKI, Jan et al.Blood. 2008, Vol 111, Num 3, pp 1094-1100, issn 0006-4971, 7 p.Article

CVP chemotherapy plus rituximab compared with CVP as first-line treatment for advanced follicular lymphomaMARCUS, Robert; IMRIE, Kevin; JACK, Andrew et al.Blood. 2005, Vol 105, Num 4, pp 1417-1423, issn 0006-4971, 7 p.Article

Rituximab Purging and/or Maintenance in Patients Undergoing Autologous Transplantation for Relapsed Follicular Lymphoma: A Prospective Randomized Trial From the Lymphoma Working Party of the European Group for Blood and Marrow TransplantationPETTENGELL, Ruth; SCHMITZ, Norbert; TO, Bik et al.Journal of clinical oncology. 2013, Vol 31, Num 13, pp 1624-1630, issn 0732-183X, 7 p.Article

Chemotherapy plus involved-field radiation in early-stage Hodgkin's diseaseFERME, Christophe; EGHBALI, Houchingue; LEDERLIN, Pierre et al.The New England journal of medicine. 2007, Vol 357, Num 19, pp 1916-1927, issn 0028-4793, 12 p.Article

  • Page / 1